XML 69 R58.htm IDEA: XBRL DOCUMENT v3.20.2
Geneos Therapeutics, Inc. - Deconsolidation Accounting (Details) - USD ($)
3 Months Ended 9 Months Ended
Jun. 01, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Noncontrolling Interest [Line Items]            
Fixed assets, net of accumulated depreciation   $ (11,190,521)   $ (11,190,521)   $ (12,773,017)
Carrying value of noncontrolling interest   96,269   96,269   $ 1,969,759
Gain on deconsolidation of Geneos   $ 0 $ 0 (4,121,075) $ 0  
Decrease in cash resulting from the deconsolidation of Geneos       $ 2,774,851 $ 0  
Geneos Therapeutics, Inc.            
Noncontrolling Interest [Line Items]            
Working capital (excluding cash) $ (59,992)          
Note payable 171,620          
Fixed assets, net of accumulated depreciation (16,340)          
Carrying value of noncontrolling interest 3,181,640          
Fair value of investment in Geneos retained 3,618,998          
Gain on deconsolidation of Geneos (4,121,075)          
Decrease in cash resulting from the deconsolidation of Geneos $ 2,774,851